Women on steroids

WHO’s statement corroborated the National Cancer Institute’s (NCI) findings in 2003, which noted a “significant increase” of the risk of breast cancer and an increased risk of cervical and liver cancers among oral contraceptive users. Regarding liver cancer, the NCI’s tip sheet states: “Several studies have found that oral contraceptives increase the risk of liver cancer in populations usually considered low risk.” The NCI’s tip sheet does mention that oral contraceptives reduce the risk of endometrial and ovarian cancers, but this should provide little solace to women given the elevated risk of breast and liver cancers.

Women on steroids

women on steroids


women on steroidswomen on steroidswomen on steroidswomen on steroidswomen on steroids